RS-56812

From WikiMD's Medical Encyclopedia

Revision as of 01:28, 20 February 2025 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

RS-56812 is a drug that acts as a potent and selective 5-HT4 receptor agonist. It has been used in scientific research to explore the role of 5-HT4 receptors in the brain and gut, and produces a range of effects such as enhancing memory and counteracting the memory-impairing effects of scopolamine, increasing the release of acetylcholine in the brain, and stimulating gastric motility in the gut.

Pharmacology[edit]

RS-56812 is a potent and selective agonist for the 5-HT4 receptor, a type of serotonin receptor found in the brain and gut. It has a high affinity for this receptor, and its effects are thought to be mediated primarily through this interaction.

Brain[edit]

In the brain, RS-56812 has been shown to enhance memory and counteract the memory-impairing effects of scopolamine, a drug that blocks the action of acetylcholine. This suggests that RS-56812 may increase the release of acetylcholine in the brain, a neurotransmitter that is involved in memory and learning.

Gut[edit]

In the gut, RS-56812 has been shown to stimulate gastric motility, the movement of food through the digestive tract. This effect is thought to be mediated through the activation of 5-HT4 receptors in the gut.

Research uses[edit]

RS-56812 has been used in scientific research to explore the role of 5-HT4 receptors in the brain and gut. It has been used in studies investigating the effects of 5-HT4 receptor activation on memory and learning, as well as on gastric motility.

See also[edit]

This article is a medical stub. You can help WikiMD by expanding it!
PubMed
Wikipedia
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.